SEC Form 4 · accession 0001193125-26-307925
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason K Garland
Officer — CFO
Period of report
Jul 16, 2026
Accepted (ET)
Jul 17, 2026 · 4:40 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 16, 2026 | S | 530 | $150.00 | D | 18,829 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 8, 2025.